BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36382667)

  • 21. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
    Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
    Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
    Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
    Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy.
    Jia Y; Ye L; Ji K; Zhang L; Hargest R; Ji J; Jiang WG
    Br J Cancer; 2014 Jan; 110(2):421-9. PubMed ID: 24300973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
    BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.
    Chiou GY; Yang TW; Huang CC; Tang CY; Yen JY; Tsai MC; Chen HY; Fadhilah N; Lin CC; Jong YJ
    Sci Rep; 2017 May; 7(1):2172. PubMed ID: 28526879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours.
    Jacques C; Fontaine JF; Franc B; Mirebeau-Prunier D; Triau S; Savagner F; Malthiery Y
    Br J Cancer; 2009 Jul; 101(1):132-8. PubMed ID: 19536094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity.
    Di Y; Jing X; Hu K; Wen X; Ye L; Zhang X; Qin J; Ye J; Lin R; Wang Z; He W
    Drug Resist Updat; 2023 Jan; 66():100909. PubMed ID: 36525936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of DELE, a novel DAP3-binding protein which is crucial for death receptor-mediated apoptosis induction.
    Harada T; Iwai A; Miyazaki T
    Apoptosis; 2010 Oct; 15(10):1247-55. PubMed ID: 20563667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.
    Hu H; Wang M; Guan X; Yuan Z; Liu Z; Zou C; Wang G; Gao X; Wang X
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29371412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
    Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
    EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT3-Mediated SOD2 and PGC-1α Contribute to Chemoresistance in Colorectal Cancer Cells.
    Paku M; Haraguchi N; Takeda M; Fujino S; Ogino T; Takahashi H; Miyoshi N; Uemura M; Mizushima T; Yamamoto H; Doki Y; Eguchi H
    Ann Surg Oncol; 2021 Aug; 28(8):4720-4732. PubMed ID: 33393034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1.
    Shan Y; Liu Y; Zhao L; Liu B; Li Y; Jia L
    Int J Biochem Cell Biol; 2017 Sep; 90():48-58. PubMed ID: 28751193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hNOA1 interacts with complex I and DAP3 and regulates mitochondrial respiration and apoptosis.
    Tang T; Zheng B; Chen SH; Murphy AN; Kudlicka K; Zhou H; Farquhar MG
    J Biol Chem; 2009 Feb; 284(8):5414-24. PubMed ID: 19103604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytosolic retention of HtrA2 during mitochondrial protein import stress triggers the DELE1-HRI pathway.
    Bi PY; Killackey SA; Schweizer L; Arnoult D; Philpott DJ; Girardin SE
    Commun Biol; 2024 Mar; 7(1):391. PubMed ID: 38555279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Death-associated protein 3 in cancer-discrepant roles of DAP3 in tumours and molecular mechanisms.
    Song H; Liu H; Wang X; Yang Y; Zhao X; Jiang WG; Sui L; Song X
    Front Oncol; 2023; 13():1323751. PubMed ID: 38352299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.